158 related articles for article (PubMed ID: 25850202)
1. Novel pyrrolopyrimidines and triazolopyrrolopyrimidines carrying a biologically active sulfonamide moieties as anticancer agents.
Ghorab MM; Alsaisd MS; Nissan YM
Acta Pol Pharm; 2015; 72(1):65-78. PubMed ID: 25850202
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and molecular docking of some novel anticancer sulfonamides carrying a biologically active pyrrole and pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Nissan YM
Acta Pol Pharm; 2014; 71(4):603-14. PubMed ID: 25272886
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
[TBL] [Abstract][Full Text] [Related]
6. Novel thiophene derivatives with sulfonamide, isoxazole, benzothiazole, quinoline and anthracene moieties as potential anticancer agents.
Ghorab MM; Bashandy MS; Alsaid MS
Acta Pharm; 2014 Dec; 64(4):419-31. PubMed ID: 25531783
[TBL] [Abstract][Full Text] [Related]
7. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; El-Hazek RM
Eur J Med Chem; 2011 Oct; 46(10):5120-6. PubMed ID: 21890248
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
Al-Said MS; Ghorab MM; Al-Qasoumi SI; El-Hossary EM; Noaman E
Eur J Med Chem; 2010 Jul; 45(7):3011-8. PubMed ID: 20413187
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of Cytotoxic Activity of Some Pyrroles and Fused Pyrroles.
Fatahala SS; Mohamed MS; Youns M; Abd-El Hameed RH
Anticancer Agents Med Chem; 2017; 17(7):1014-1025. PubMed ID: 28042776
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-breast cancer evaluation of novel N-(guanidinyl)benzenesulfonamides.
Ghorab MM; El-Gazzar MG; Alsaid MS
Int J Mol Sci; 2014 Apr; 15(4):5582-95. PubMed ID: 24694543
[TBL] [Abstract][Full Text] [Related]
12. DESIGN, SYNTHESIS AND ANTICANCER ACTIVITY OF SOME NOVEL 1,2,4-TRIAZOLES CARRYING BIOLOGICALLY ACTIVE SULFONAMIDE MOIETIES.
Ghorab MM; Alsaid MS; Al-Dosari M
Acta Pol Pharm; 2016 Sep; 73(5):1147-1153. PubMed ID: 29638055
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and pharmacological evaluation of novel pyrrolizine derivatives as potential anticancer agents.
Gouda AM; Abdelazeem AH; Arafa el-SA; Abdellatif KR
Bioorg Chem; 2014 Apr; 53():1-7. PubMed ID: 24462996
[TBL] [Abstract][Full Text] [Related]
14. Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents.
Al-Dosari MS; Ghorab MM; Al-Said MS; Nissan YM
Chem Pharm Bull (Tokyo); 2013; 61(1):50-8. PubMed ID: 23302586
[TBL] [Abstract][Full Text] [Related]
15. Anti-breast cancer activity of some novel quinoline derivatives.
Ghorab MM; Alsaid MS
Acta Pharm; 2015 Sep; 65(3):271-83. PubMed ID: 26431105
[TBL] [Abstract][Full Text] [Related]
16. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety.
Ghorab MM; Shaaban MA; Refaat HM; Heiba HI; Ibrahim SS
Eur J Med Chem; 2012 Jul; 53():403-7. PubMed ID: 22583778
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of some new pyrazole and pyrimidine derivatives carrying a sulfonamide moiety of expected antitumor activity and study of the synergistic effect of gamma-irradiation.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; Galal M
Arzneimittelforschung; 2010; 60(1):48-55. PubMed ID: 20184227
[TBL] [Abstract][Full Text] [Related]
18. A promising anti-cancer and anti-oxidant agents based on the pyrrole and fused pyrrole: synthesis, docking studies and biological evaluation.
Fatahala SS; Shalaby EA; Kassab SE; Mohamed MS
Anticancer Agents Med Chem; 2015; 15(4):517-26. PubMed ID: 25929576
[TBL] [Abstract][Full Text] [Related]
19. Novel 4-aminoquinazoline derivatives as new leads for anticancer drug discovery.
Ghorab MM; Alsaid MS
Acta Pharm; 2015 Sep; 65(3):299-309. PubMed ID: 26431107
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and docking studies of some novel quinoline derivatives bearing a sulfonamide moiety as possible anticancer agents.
Ghorab MM; Ragab FA; Hamed MM
Arzneimittelforschung; 2010; 60(3):141-8. PubMed ID: 20422946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
